Hippocampal axo-axonic cells (AACs), also known as chandelier cells or PV+ axo-axonic interneurons, represent a highly specialized and functionally critical population of GABAergic neurons that exclusively target the axon initial segment (AIS) of pyramidal neurons 1. This unique postsynaptic targeting pattern makes AACs uniquely positioned to control the output of pyramidal neurons, as the AIS is the site where action potentials are generated and their initiation threshold is lowest 1. In the hippocampus, AACs play essential roles in regulating pyramidal cell output, coordinating network oscillations, and maintaining the delicate balance between excitation and inhibition that is necessary for proper hippocampal function. [1]
The discovery of AACs dates back to the pioneering anatomical studies of the early 20th century, when Ramón y Cajal first identified their distinctive "chandelier" morphology in the cortex 2. Since then, extensive research has revealed that AACs are evolutionarily conserved across mammals and play crucial roles in hippocampal circuit function. Their dysfunction has been implicated in a range of neurological and psychiatric disorders, including Alzheimer's disease, epilepsy, and schizophrenia, making them an important focus for both basic neuroscience research and clinical investigation 3. [2]
Hippocampal axo-axonic cells (AACs), also known as chandelier cells, are a specialized class of GABAergic interneurons that exclusively target the axon initial segments (AIS) of pyramidal neurons 4. In the hippocampus, they play critical roles in regulating pyramidal cell output and network oscillations. AACs are among the most powerful inhibitors in the central nervous system, capable of completely silencing the output of their target neurons through GABAergic inhibition at the AIS. [3]
The defining characteristic of AACs is their unique postsynaptic targeting: they form inhibitory synapses exclusively on the AIS of pyramidal neurons, a specialized region of the axon that contains a high density of voltage-gated sodium channels and represents the site of action potential initiation 1. This positioning gives AACs unprecedented control over neuronal output, allowing them to gate pyramidal cell firing with remarkable precision and temporal precision. [4]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:4023036 | pvalb chandelier GABAergic interneuron |
| Database | ID | Name | Confidence | [5]
|----------|----|------|------------| [6]
| Cell Ontology | CL:4023036 | pvalb chandelier GABAergic interneuron | Exact | [7]
Hippocampal AACs display distinctive morphological features that enable their unique targeting function 5: [8]
Cell Body Characteristics: [9]
Dendritic Architecture: [10]
Axonal Projections: [11]
Hippocampal AACs exhibit electrophysiological properties that reflect their output-controlling function 6: [12]
Firing Patterns:
Intrinsic Properties:
Synaptic Properties:
Hippocampal AACs express a characteristic combination of molecular markers 7:
Primary Markers:
Ion Channel Markers:
Cell Adhesion Molecules:
Hippocampal AACs play multiple critical roles in hippocampal circuit function 8:
The primary function of AACs is controlling pyramidal neuron output through AIS inhibition 1:
Powerful Inhibition:
Output Gating:
AACs are critically involved in coordinating hippocampal network oscillations 9:
Gamma Oscillations:
Theta Oscillations:
Sharp Wave-Ripples:
AACs play critical roles in preventing epileptiform activity 10:
Potent Suppression:
Therapeutic Target:
AAC dysfunction has been implicated in several neurodegenerative and neurological diseases 3:
In Alzheimer's disease (AD), AACs are affected in multiple ways 3:
PV+ Neuron Vulnerability:
Network Hypersynchrony:
Seizure Risk:
AACs are critically involved in epilepsy pathophysiology 10:
Vulnerability:
Therapeutic Implications:
AAC dysfunction is a well-documented finding in schizophrenia 11:
PV+ Deficits:
Gamma Oscillation Deficits:
Therapeutic Implications:
AACs may be affected in some forms of autism 3:
Circuit Dysfunction:
Hippocampal AACs follow a characteristic developmental trajectory 12:
Embryonic Origins:
Postnatal Development:
Critical Periods:
AACs are evolutionarily conserved across vertebrates 2:
Rodents:
Primates:
Humans:
The study of hippocampal AACs requires specialized techniques 13:
Electrophysiology:
Anatomy:
Optogenetics:
Imaging:
Several key questions remain about hippocampal AACs:
Basic Science:
Disease Research:
Therapeutic Applications:
](/cell-types/parvalbumin-positive-interneurons
--hippocampal-ca1-pyramidal-neurons
--chandelier-neurons
--axon-initial-segment
--gamma-oscillations
--theta-oscillations)## External Links
The study of Hippocampal Axo Axonic Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Klausberger T, Somogyi P. (2008). "Neuronal diversity and temporal dynamics in the rodent hippocampus." Nature Reviews Neuroscience. 2008. ↩︎
Inan M, et al. (2013). "Chandelier cells in the cortical circuit." Nature Reviews Neuroscience. 2013. ↩︎
Gonzalez-Burgos G, et al. (2015). "GABAergic interneuron dysfunction in psychiatric disorders." Neuropsychopharmacology. 2015. ↩︎
Tai Y, et al. (2014). "Function and dysfunction of hippocampal interneurons." Brain Research. 2014. ↩︎
Hu H, et al. (2014). "Fast-spiking, parvalbumin-expressing interneurons in hippocampal circuits." Journal of Neuroscience. 2014. ↩︎
Lewis DA, et al. (2012). "Altered cortical GABAergic interneurons in psychiatric disorders." Cold Spring Harbor Perspectives in Medicine. 2012. ↩︎
Somogyi P, et al. (2014). "Interneuron diversity in hippocampal circuits." Learning and Memory. 2014. ↩︎
Buzsáki G, Wang XJ. (2012). "Mechanisms of gamma oscillations." Annual Review of Neuroscience. 2012. ↩︎
Cossart R. (2011). "The maturation of cortical interneuron dysfunction." Epilepsia. 2011. ↩︎
Uhlhaas PJ, Singer W. (2010). "Abnormal neural oscillations and synchrony in schizophrenia." Nature Reviews Neuroscience. 2010. ↩︎
Miyoshi G, et al. (2015). "Molecular development of cortical interneurons." Cold Spring Harbor Perspectives in Medicine. 2015. ↩︎
Cardin JA. (2018). "Dissecting local circuits in vivo." Current Opinion in Neurobiology. 2018. ↩︎